Table 1 Characteristics of Eligible Guidelines
Guideline | Country | Developer | CAM Category | Guideline Topic |
|---|---|---|---|---|
Macaluso et al. 2022 [36] | Italy | Italian Group for the study of Inflammatory Bowel Disease | None | Pharmacologic management of moderate to severe UC |
Austria | European Crohn’s and Colitis Organisation | Probiotics | Medical and surgical treatment of UC | |
De Simone et al. 2021 [39] | Italy; United States | World Society of Emergency Surgery; American Association for the Surgery of Trauma | None | Emergency management of IBD |
Feuerstein et al. 2021 [40] | United States | American Gastroenterological Association | None | Pharmacologic management of moderate to severe luminal and perianal fistulizing CD |
Holubar et al. 2021 [41] | United States | American Gastroenterological Association | None | Surgical management of UC |
Lodyga et al. 2021 [42] | Poland | Polish Society of Gastroenterology; Polish National Consultant in Gastroenterology | Vitamins and Minerals | Management of CD |
Miehlke et al. 2021 [43] | Austria; Sweden | United European Gastroenterolog; European Microscopic Colitis Group | Vitamins and Minerals | Management of microscopic colitis |
Nakase et al. 2021 [44] | Japan | Japanese Society of Gastroenterology | None | Management of IBD |
Adamina et al. 2020 [45] | Austria | European Crohn’s and Colitis Organisation | None | Surgical treatment of CD |
Feuerstein et al. 2020 [46] | United States | American Gastroenterological Association | None | Management of moderate to severe UC |
Levine et al. 2020 [47] | United States | American Gastroenterological Association | Dietary Supplements | Dietary management of IBD |
Colombel et al. 2019 [48] | United States | American Gastroenterological Association | Fecal Microbiota Transplantation, Hypnotherapy, Mindfulness, Probiotics | Management of IBD functional gastrointestinal symptoms |
Lightner et al. 2020 [49] | United States | American Society of Colon and Rectal Surgeons | None | Surgical management of CD |
Shen et al. 2020 [50] | United States* | Global Interventional Inflammatory Bowel Disease Group | None | Endoscopic treatment of CD |
Torres et al. 2020 [51] | Austria | European Crohn’s and Colitis Organisation | None | Pharmacologic treatment of CD |
Bonnaud et al. 2019 [52] | France | National Association of the Hepato-gastroenterologists of the National Hospitals Reflexion Club of the Practices and Groups in Hepato-gastroenterology Group for the Study of Treatments for Inflammatory Affectations of the Digestive Tube AFA Crohn-RCH France | None | Management of CD perianal fistulas |
Ko et al. 2019 [53] | United States | American Gastroenterological Association | Herbals, Probiotics | Management of mild to moderate UC |
Kucharzik et al. 2019 [54] | Germany | German Society for Gastroenterology, Digestive and Metabolic Diseases | Acupuncture, Fecal Microbiota Transplantation, Herbals, Mind-body Medicine, Probiotics | Management of UC |
National Institute for Health and Care Excellence (NICE) 2019 [55] | United Kingdom | National Institute for Health and Care Excellence (NICE) | None | Management of UC |
Canada | Canadian Association of Gastroenterology | Cannabis, Dietary Supplements, Probiotics | Management of luminal CD | |
Rubin et al. 2019 [58] | United States | American College of Gastroenterology | Herbals, Probiotics | Management of UC in adults |
Sood et al. 2019 [59] | India* | Asian Working Group | Dietary Patterns, Probiotics | Dietary management of IBD |
Steinhart et al. 2019 [60] | Canada | Canadian Association of Gastroenterology | None | Management of perianal fistulizing CD |
Teixeira et al. 2019 [61] | Brazil | Brazilian Medical Association | None | Biologicals treatment of UC |
Zaltman et al. 2019 [62] | Brazil | Brazilian Medical Association | None | Biologicals treatment of CD |
Bemelman et al. 2018 [63] | Austria | European Crohn’s and Colitis Organisation | None | Surgical treatment of CD |
Brown et al. 2018 [64] | United Kingdom | Association of Coloproctology of Great Britain and Ireland | Fecal Microbiota Transplantation, Probiotics | Surgical treatment of IBD |
Lichtenstein et al. 2018 [65] | United States | American College of Gastroenterology | Dietary Therapies | Management of CD in adults |
Forbes et al. 2017 [66] | Luxembourg | European Society for Clinical Nutrition and Metabolism | Dietary Patterns, Dietary Supplements, Probiotics, Vitamins and Minerals | Nutritional management of IBD |
Gionchetti et al. 2017 [67] | Italy | Italian Group for the Study of Inflammatory Bowel Disease | None | Corticosteroid and immunosuppressive treatment of IBD |
Nguyen et al. 2017 [68] | United States | American Gastroenterological Association | Probiotics | Management of CD in post-surgical resection patients |
Bernstein et al. 2016 [69] | Canada | World Gastroenterology Organisation | Cannabis, Ispaghula, Probiotics | Management of IBD |
Harbord et al. 2016 [70] | Austria | European Crohn’s and Colitis Organisation | Vitamins and Minerals | Management of IBD extraintestinal manifestations |
Bressler et al. 2015 [71] | Canada | Canadian Association of Gastroenterology | Fecal Microbiota Transplantation, Probiotics | Management of UC in non-hospitalized patients |
Eliadou et al. 2015 [72] | New Zealand | New Zealand Society of Gastroenterology | Fecal Microbiota Transplantation | Management of refractory UC |
Fichera & Zoccali 2015 [73] | United States | Crohn’s & Colitis Foundation of America | Adipose-derived Stem Cells | Surgical treatment of perianal fistulizing CD |
Schwartz et al. 2015 [74] | United States | Crohn’s & Colitis Foundation of America | None | Management of perianal fistulizing CD |
Strong et al. 2015 [75] | United States | American Society of Colon and Rectal Surgeons | None | Surgical treatment of CD |
Gecse et al. 2014 [76] | United States | World Gastroenterology Organization | None | Management of perianal fistulizing CD |
Lee et al. 2014 [77] | United Kingdom | British Dietetic Association | Probiotics | Dietary management of CD |
Ross et al. 2014 [78] | United States | American Society of Colon and Rectal Surgeons | Probiotics | Surgical treatment of UC |
Gomollon et al. 2013 [79] | Spain | Spanish Group of Ulcerative Colitis and Crohn’s Disease | None | Management of UC |
Leung et al. 2013 [80] | China | Hong Kong IBD Society | None | Biological treatment of IBD |
Terdiman et al. 2013 [81] | United States | American Gastroenterological Association | None | Thiopurines, methotrexate, and anti-TNF-α treatment of CD |
Theede et al. 2013 [82] | Denmark | Danish Society of Gastroenterology and Hepatology | None | Biologicals treatment of IBD |
Ueno et al. 2013 [83] | Japan | Guidelines Project Group of the Research Group of Intractable Inflammatory Bowel Disease | Dietary patterns | Management of CD |
Bitton et al. 2012 [84] | Canada | Canadian Association of Gastroenterology | None | Treatment of severe UC in hospitalized adults |
Mowat et al. 2011 [85] | United Kingdom | British Society of Gastroenterology | Dietary patterns, Probiotics, Vitamins and Minerals | Management of IBD in adults |
Orlando et al. 2011 [86] | Italy | Italian Society of Gastroenterology; Italian Group for the study of Inflammatory Bowel Disease | None | Anti-TNF-α treatment of IBD |